Isa PMA

Language: Spanish
References: 7
Page: 85-86
PDF size: 186.40 Kb.

Text Extraction

No abstract.

REFERENCES

1. Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Therapy Lett. 2016; 21 (1): 1-7.

2. Sadeghpour M, Dover JS, Rohrer TE. Advances in the treatment of melasma. Advances in Cosmetic Surgery. 2018; 1 (1): 163-174.

3. Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011; 65 (4): 689-697.

4. Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007; 46 (2): 111-116.

5. Bak H, Lee HJ, Chang SE, Choi JH, Kim MN, Kim BJ. Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma. Dermatol Surg. 2009; 35 (8): 1244-1250.

6. Jutley GS, Rajaratnam R, Halpern J, Salim A, Emmett C. Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review. J Am Acad Dermatol. 2014; 70 (2): 369-73.

7. Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg. 2018; 44 (6): 814-825.